210 related articles for article (PubMed ID: 30617094)
21. Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals.
McDanel JS; Perencevich EN; Diekema DJ; Herwaldt LA; Smith TC; Chrischilles EA; Dawson JD; Jiang L; Goto M; Schweizer ML
Clin Infect Dis; 2015 Aug; 61(3):361-7. PubMed ID: 25900170
[TBL] [Abstract][Full Text] [Related]
22. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
[TBL] [Abstract][Full Text] [Related]
23. What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant
García Aragonés L; Blanch Sancho JJ; Segura Luque JC; Mateos Rodriguez F; Martínez Alfaro E; Solís García Del Pozo J
Postgrad Med J; 2022 Jan; 98(1155):48-56. PubMed ID: 33563707
[TBL] [Abstract][Full Text] [Related]
24. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.
Murray KP; Zhao JJ; Davis SL; Kullar R; Kaye KS; Lephart P; Rybak MJ
Clin Infect Dis; 2013 Jun; 56(11):1562-9. PubMed ID: 23449272
[TBL] [Abstract][Full Text] [Related]
25. Analysis of synergy between beta-lactams and anti-methicillin-resistant Staphylococcus aureus agents from the standpoint of strain characteristics and binding action.
Ono D; Yamaguchi T; Hamada M; Sonoda S; Sato A; Aoki K; Kajiwara C; Kimura S; Fujisaki M; Tojo H; Sasaki M; Murakami H; Kato K; Ishii Y; Tateda K
J Infect Chemother; 2019 Apr; 25(4):273-280. PubMed ID: 30713034
[TBL] [Abstract][Full Text] [Related]
26. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
Moise PA; Culshaw DL; Wong-Beringer A; Bensman J; Lamp KC; Smith WJ; Bauer K; Goff DA; Adamson R; Leuthner K; Virata MD; McKinnell JA; Chaudhry SB; Eskandarian R; Lodise T; Reyes K; Zervos MJ
Clin Ther; 2016 Jan; 38(1):16-30. PubMed ID: 26585355
[TBL] [Abstract][Full Text] [Related]
27. Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial.
Legg A; Meagher N; Johnson SA; Roberts MA; Cass A; Scheetz MH; Davies J; Roberts JA; Davis JS; Tong SYC
Clin Drug Investig; 2023 Jan; 43(1):23-33. PubMed ID: 36217068
[TBL] [Abstract][Full Text] [Related]
28. Systematic review and meta-analysis of the efficacy and safety of vancomycin combined with β-lactam antibiotics in the treatment of methicillin-resistant Staphylococcus aureus bloodstream infections.
Ye C; Wang Z; Hu Y; Deng C; Liao L; Sun L; Wang C
J Glob Antimicrob Resist; 2020 Dec; 23():303-310. PubMed ID: 33045437
[TBL] [Abstract][Full Text] [Related]
29. High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia.
Aguado JM; San-Juan R; Lalueza A; Sanz F; Rodríguez-Otero J; Gómez-Gonzalez C; Chaves F
Emerg Infect Dis; 2011 Jun; 17(6):1099-102. PubMed ID: 21749780
[TBL] [Abstract][Full Text] [Related]
30. Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial.
Davis JS; Sud A; O'Sullivan MVN; Robinson JO; Ferguson PE; Foo H; van Hal SJ; Ralph AP; Howden BP; Binks PM; Kirby A; Tong SYC; ; ; Tong S; Davis J; Binks P; Majumdar S; Ralph A; Baird R; Gordon C; Jeremiah C; Leung G; Brischetto A; Crowe A; Dakh F; Whykes K; Kirkwood M; Sud A; Menon M; Somerville L; Subedi S; Owen S; O'Sullivan M; Liu E; Zhou F; Robinson O; Coombs G; Ferguson P; Ralph A; Liu E; Pollet S; Van Hal S; Foo H; Van Hal S; Davis R
Clin Infect Dis; 2016 Jan; 62(2):173-180. PubMed ID: 26349552
[TBL] [Abstract][Full Text] [Related]
31. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.
Jacobson LM; Milstone AM; Zenilman J; Carroll KC; Arav-Boger R
Pediatr Infect Dis J; 2009 May; 28(5):445-7. PubMed ID: 19295462
[TBL] [Abstract][Full Text] [Related]
32. Association Between Vancomycin Trough Concentrations and Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.
Hsu AJ; Hamdy RF; Huang Y; Olson JA; Ghobrial S; Gerber JS; Hersh AL; Tamma PD
J Pediatric Infect Dis Soc; 2018 Dec; 7(4):338-341. PubMed ID: 28992126
[TBL] [Abstract][Full Text] [Related]
33. Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection.
Takata T; Miyazaki M; Futo M; Hara S; Shiotsuka S; Kamimura H; Yoshimura H; Matsunaga A; Nishida T; Ishikura H; Ishikawa T; Tamura K; Tsuji BT
Scand J Infect Dis; 2013 Mar; 45(3):203-12. PubMed ID: 23113753
[TBL] [Abstract][Full Text] [Related]
34. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia.
Khatib R; Saeed S; Sharma M; Riederer K; Fakih MG; Johnson LB
Eur J Clin Microbiol Infect Dis; 2006 Mar; 25(3):181-5. PubMed ID: 16505987
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus.
Casapao AM; Davis SL; McRoberts JP; Lagnf AM; Patel S; Kullar R; Levine DP; Rybak MJ
Antimicrob Agents Chemother; 2014 Aug; 58(8):4636-41. PubMed ID: 24890596
[TBL] [Abstract][Full Text] [Related]
36. Teicoplanin versus β-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia.
Tsai CY; Lee CH; Chen IL
BMC Infect Dis; 2021 May; 21(1):437. PubMed ID: 33980167
[TBL] [Abstract][Full Text] [Related]
37. [Persistent bacteremia due to methicillin-resistant Staphylococcus aureus. A result of inadequate treatment].
Parra-Ruiz J; Tomas-Jiménez C; Muñoz-Medina L; Hernández-Quero J
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):372-3. PubMed ID: 19339080
[No Abstract] [Full Text] [Related]
38. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
[TBL] [Abstract][Full Text] [Related]
39. Administration of a β-Lactam Prior to Vancomycin as the First Dose of Antibiotic Therapy Improves Survival in Patients With Bloodstream Infections.
Amoah J; Klein EY; Chiotos K; Cosgrove SE; Tamma PD
Clin Infect Dis; 2022 Aug; 75(1):98-104. PubMed ID: 34606585
[TBL] [Abstract][Full Text] [Related]
40. Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia.
Britt NS; Patel N; Shireman TI; El Atrouni WI; Horvat RT; Steed ME
J Antimicrob Chemother; 2017 Feb; 72(2):535-542. PubMed ID: 27999028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
